July 2021

Contents

Editorial

• HTB: no. 7 – plus HIV and COVID-19 (1 July 2021)

Conference reports

• 5th Joint BHIVA/BASHH Conference 2021

• Few vertical HIV transmissions in the UK but contributing factors remain associated with inequality

Antiretrovirals

• Lenacapavir submitted to FDA as long-acting treatment for MDR HIV

Guidelines

• US HIV treatment guidelines updated (June 2021)

Cure-related research

• Predicting likelihood of post treatment control in HIV cure-related studies that interrupt ART

COVID-19: HIV and COVID-19 coinfection

• London HIV study of responses to COVID-19 vaccines and natural infection (SCAPE)

• mRNA vaccine fails to produce antibody response in late-stage HIV: low CD4 count and high viral load

COVID-19: vaccine research

• Special report on background incidence of adverse events in vaccine studies

• Third vaccine dose increases immune response to 68% in French transplant recipients

• Third COVID-19 vaccine dose in US cohort of people on immune-suppressing treatment: safety and ethical issues

• Plans for universal third vaccine dose for UK adults from September

• COVID-19 vaccines increase sperm quality: potential to help uptake

COVID-19: investigational drugs

• Research approach to rapidly review candidate treatments for COVID-19: nine studies using ACTIV protocol

• COVID-19 treatment: tofacitinib, REGN bNAbs, convalescent plasma

COVID-19: transmission & prevention

• US likely to have had SARS cases in December 2020

COVID-19: on the web

• Virology Education: monthly forums on COVID-19

• COVID-19 timeline: global events from the last 18 months

• COVIDsalon

PDFs

• HTB: no. 7 – plus HIV and COVID-19 (1 July 2021)